An interventional study of Family-based Treatment for ARFID and Manualized Non-Specific Usual Care for ARFID in Avoidant/Restrictive Food Intake Disorder, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Stanford University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Avoidant Restrictive Food Intake Disorder with a site in United States — 7 open to participants now, 7 under way, none of them phase 3. Avoidant Restrictive Food Intake Disorder · United States.
Among the 23 studies in Avoidant Restrictive Food Intake Disorder with a site in United States, this one is the 2nd largest by enrollment of the 18 interventional ones that give a count, is the only one that started in 2020, is one of 17 with no phase, and was the 4th registered.
41 studies on the registry are indexed under Avoidant Restrictive Food Intake Disorder; 12 are open to participants now.
Browse Avoidant Restrictive Food Intake Disorder studies →7 of the 23 studies in Avoidant Restrictive Food Intake Disorder with a site in United States are open now. Recruiting first, the newest first:
Massachusetts General Hospital · Sites in United States
Ages 10–18
Massachusetts General Hospital · Sites in United States
Ages 18–55
University of North Carolina, Chapel Hill · Sites in United States, Australia, Mexico and 2 more countries
Ages 12–99 · Healthy volunteers
Brain Inflammation Collaborative · Sites in United States
Ages 2+ · Healthy volunteers
University of Louisville · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 8 Avoidant Restrictive Food Intake Disorder studies recruiting now, 3 set no upper age limit and 4 stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.
This study: 6 Years to 12 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 1 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 285 is above the median of 38 across 28 interventional studies indexed under Avoidant Restrictive Food Intake Disorder.
Median enrollment 38 across the 18 interventional studies, 5,076 across the 5 observational. Of the 15 that completed or were terminated, 3 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 23 has an industry lead sponsor. The 10 most frequent:
Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
Stanford University has 2 studies filed under Avoidant Restrictive Food Intake Disorder — fewer than ten, so there is no comparison to draw.
2 of the studies in Avoidant Restrictive Food Intake Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05587127Massachusetts General HospitalExposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia | 2027-05 |
| NCT06594913University of North Carolina, Chapel HillEating Disorders Genetics Initiative 2 | 2027-09-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 23 studies in Avoidant Restrictive Food Intake Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is examining the efficacy and mechanism of family therapy compared to usual care for children between the ages of 6 and 12 who are diagnosed with Avoidant/Restrictive Food Intake Disorder. Preliminary data suggest that family therapy is superior to usual care and that improvement in parental self-efficacy related to feeding their children is the mechanism of treatment. In addition, this study will attempt to identify specific patient groups who respond to family therapy.
Potential subjects aged 6 years to 12 years, 11 months old with DSM 5 ARFID, and weight equal to or between 75 to 88% EBW who are medically stable for outpatient treatment and their families will be recruited through Stanford University, pediatricians, mental health experts, clinics treating EDs, and local parents' groups. Those eligible for the program will be invited to read and sign informed consent forms and complete the baseline assessment. Participants will then be randomized to FBT-ARFID with medical management for 14 sessions provided over 4 months or manualized Non-Specific Care (NSC) with medical management for 4 months. NSC will consist of 14 sessions over 4 months.
There will be 5 major assessment time points: Baseline, 1 month, 2 months, End Of Treatment (4 months), and 6-month post-treatment Follow-Up. Both the child and the parent will complete measures at these time points. In addition, parents will complete short survey assessments after each of the 14 treatment sessions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.
The study may name a correction formula and a limit in milliseconds, often around 450–480.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
QT and QTc
On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.
The study may name a correction formula and a limit in milliseconds, often around 450–480.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
FBT-ARFID is a manualized treatment based on the model of FBT that employs the same interventions as standard FBT for AN and BN: externalization, agnosticism, parental empowerment, a behavioral focus on changing eating behavior. Early sessions focus on inciting parents to make changes and include a family meal that allows therapists to observe \& consult directly to mealtime behaviors. FBT-ARFID for children 12 and under is manualized and consists of 2 phases. The first phase is focused on parents taking charge \& changing the eating behaviors of their child that are maintaining ARFID. The second phase focuses on the child taking up in an age-appropriate way managing their eating consistent with the changes the parents have employed in phase 1. Fourteen 1-hour sessions will be conducted approximately weekly over 4 months. Throughout medical monitoring and weekly dietary consultation are available to the family.
Behavioral: Family-based Treatment for ARFID
A manualized non-specific psycho-educational and motivational enhancement approach that is based on a supportive non-directive psychotherapy model that has been used in other RCTs with eating disorders as a comparison. NSC consists of sessions with the child alone and 5 parent-only meetings. Sessions are 1-hour. NSC matches FBT-ARFID for time and therapist attention. The focus of the NSC intervention is psychoeducation about health \& social impacts of restrictive eating and supporting parent \& child exploration of motivation to change eating patterns \& choices they make about changes to eating. The therapist does not initiate behavioral or cognitive interventions. Feelings about eating and making changes are explored in both the child and parent sessions. Medical and dietary advice are provided weekly.
Behavioral: Manualized Non-Specific Usual Care for ARFID
This treatment includes 14 1-hour sessions that will be conducted approximately weekly over a 4 month period. It is a manualized treatment based on the model of FBT that employs the same interventions as standard FBT for AN and BN: externalization, agnosticism, parental empowerment, a behavioral focus on changing eating behavior.
Also known as: FBT-ARFID
This treatment is a manualized non-specific psycho-educational and motivational enhancement approach that is based on a supportive non-directive psychotherapy model. It consists of sessions with the child alone and 5 parent-only meetings, all of which are 1-hour over a 4 month period.
Also known as: NSC
Expected Body Weight (EBW)
Expected Body Weights (EBW) percentages used will be calculated using Center for Disease Control Growth Chart metrics in children and adolescents with weight adjusted for age, gender, and height.
Time frame: 4 months
Parents Versus Avoidant/Restrictive Food Intake Disorder (ARFID)
A modification of the Parents versus Anorexia Nervosa Scale, a measure of parental self-efficacy at changing eating behaviors. The modifications to the scale are minor and consisted of changing the name of the disorder named in the scale's questions from AN to ARFID. This is a 7 item 5 point scale (for an overall score range of 7 to 35), where higher scores mean greater parental self-efficacy.
Time frame: 4 months
Parental Feeding Behavior Assessment
Meals are recorded by video and then coded for behaviors associated with successful re-feeding using a procedure developed for Family Based Treatment. Criticisms were counts of critical comments to the child. Warmth was counts of positive comments to the child. Physical behaviors were counts of non-verbal praise and support to eat such as rubbing the child's back or loading the child's fork. Directives were counts of direct statements to the child to eat, try a food, or take a bite. Indirectives were statements to the child suggesting that they eat, try a food, or take a bite.
Time frame: Baseline and week 6
The Pica, ARFID, Rumination Disorder Interview (PARDI)
The Pica, ARFID, Rumination Disorder Interview (PARDI) is a semi-structured interview designed to diagnose and evaluate symptom severity of Avoidant/Restrictive Food Intake Disorder (ARFID). Parents reported on their child's behavior using the PARDI. The severity score is comprised of 17 items on a 7 point scale (for an overall score range of 0 to 6), where greater scores indicate greater ARFID symptom severity.
Time frame: All assessment time points (Baseline, 1 month, 2 months, 4 months, and 10-months)
Therapy Suitability and Patient Expectancy (TSPE)
The Therapy Suitability and Patient Expectancy Scale is a measure with two subscales (Suitability and Success) and 2 items on 11 point scale (for an overall score of 0 to 10 on each subscale) that measures perceptions of the suitability and expectancy of the treatment provided and will be rated by parents. Higher scores on the subscales indicates greater perceptions of suitability and success. There is no TSPE total score.
Time frame: At the end of session 1 (approximately 1 week following baseline), and end of sessions 3, 5, 7, 9, 11, and 13.
Parenting Style Questionnaire (PSQ)
The Parenting Style Questionnaire is a 30 item 6 point validated measure of parenting style related to authoritative, authoritarian, and permissive style. This questionnaire is divided up into three subscales: authoritative (13 questions), authoritarian (13 questions), and permissive (4 questions). Each question was rated on a scale of 1 to 6. Item scores in each subscale were summed and averaged to create the subscale score (range: 1 to 6). For all question and subscale scores, greater scores suggest the more preferred parenting style. This questionnaire will be completed by parents/caregivers.
Time frame: Completed at baseline and 4 months
Center for Epidemiological Studies Depression Scale for Children (CES-DC)
The Center for Epidemiological Studies Depression Scale for Children is a 20-item 4 point self-report scale (for an overall score range of 0 to 60) that measures child depression, with higher scores suggesting greater depressive symptoms.
Time frame: Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).
Revised Children's Manifest Anxiety Scale (RCMAS-2) Short
The Revised Children's Manifest Anxiety Scale Short is a 10 item 2 point scale (for an overall score range of 0 to 10) and is a validated measure of childhood anxiety and will be completed by children, with higher scores suggesting greater anxiety symptoms.
Time frame: Completed by children at all major assessment timepoints (Baseline, 1 month, 2 months, 4 months, and 10-months).
Helping Alliance Questionnaire (HAQ)
The HAQ is an 11-item survey, each item scored on a 6 point scale (scores of -3, -2, -1, 1, 2, 3). This questionnaire measures the quality of the therapist-patient relationship. The form is divided up into two subscales: Helpfulness (5 questions for an score range of -15 to 15) and Cooperation (6 questions for a score range of -18 to 18). For each subscale, higher scores correspond to a more positive relationship and perception of the therapist's helpfulness and cooperation. The HAQ will be completed by parents/caregivers.
Time frame: Completed by parents after treatment sessions 1, 3, 5, 7, 9, 11, and 13, and at major assessment points at 1 month, 2 months, 4 months, and 10-months.
Number of Participants With Disorders Identified Using the Schedule for Affective Disorders and Schizophrenia for School-Aged Children (6-18 Years) (K-SADS)
The Schedule for Affective Disorders and Schizophrenia for School-Aged Children (K-SADS) is a widely used semi-structured interview detecting psychiatric disorders in children and adolescents. The individual items are scored on a 0 to 3 point rating scale, with scores of a 3 representing threshold criteria that leads to an additional diagnostic supplement based on the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) criteria evidence of the disorder. The K-SADS was administered to ascertain co-morbid psychiatric diagnoses prior to starting treatment.
Time frame: Completed by parents on behalf of their child at baseline.
Strengths and Difficulties Questionnaire (SDQ)
The Strengths and Difficulties Questionnaire assesses conduct, social, and peer behaviors consists of 25 items (questions) each rated on a scale from 0 to 2. The SDQ has with 5 subscales (emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship, and prosocial behavior). Each subscale consists of 5 questions resulting in a subscale score range of 0-10 (higher scores scores correspond to greater difficulties, except for prosocial behavior, where higher scores correspond to fewer difficulties). The total difficulties score is generated by summing scores from all the subscales except prosocial behavior, to create an overall score range of 0-40, where higher scores mean greater difficulties.
Time frame: Completed by parents at all major assessment points (Baseline, 1 month, 2 months, 4 months, and 10-months).
Beck Depression Inventory (BDI)
The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression on a 4-point scale (overall scores ranging from 0 to 63). This measure also includes questions about suicidal ideation and intent. Higher scores suggest greater depressive symptoms.
Time frame: Completed by parents at baseline and 4 months
Beck Anxiety Inventory (BAI)
The Beck Anxiety Inventory consists of 21 self-reported items assessing a participant's anxiety symptoms on a 4-point (0 to 3) scale (for an overall score range of 0 to 63), where higher scores suggests greater anxiety symptoms.
Time frame: Completed by parents at baseline and 4 months.
36-Item Short Form (SF-36)
The 36-Item Short Form is a 36 item scale and is a general measure of physical and mental health functioning. This form is divided up into 8 subscales: vitality (4 questions), physical functioning (10 questions), bodily pain (2 questions), general health perceptions (5 questions), physical role functioning (4 questions), emotional role functioning (3 questions), social role functioning (2 questions), and mental health (5 questions). 1 question is not included in subscale scoring. The questions range between 2 and 6 points (1 to 2, 1 to 3, 1 to 5, and 1 to 6) and then are each re-coded (scale of 0 to 100), summed, and averaged to create the subscale score (score range of 0 to 100). For all subscales scores, greater scores suggest less disability. This assessment will be taken by the parents/caregivers.
Time frame: Completed by parents at baseline
Bandura's General Self-Efficacy Scale (GSES)
Bandura's General Self-Efficacy Scale is a 10-item 4 point self-report scale (for an overall score range of 10 to 40) of general self-efficacy, where higher scores mean higher self-efficacy. This measure was completed by parents for their general self-efficacy score.
Time frame: Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.
Parental Sense of Competence Scale (PSOC)
The Parenting Sense of Competence Scale contains 17 items measuring a participant's sense of competence in their parenting skills and as a parent of a child on a 6 scale (for an overall score range of 17 to 102), with higher scores meaning greater parental efficacy.
Time frame: Completed by parents at all major assessment time-points (Baseline, 1 month, 2 months, 4 months, and 10-months) as well as after each of the 14 weekly treatment sessions.
This study enrolled family dyads, including children between the ages of 6 and 12 diagnosed with Avoidant/Restrictive Food Intake Disorder (ARFID) and their parent(s) or caregiver(s). The study consisted of 14 weekly sessions that started approximately 1 week after baseline, with separate major assessment time points at baseline, 1 month, 2 months, 4 months (end of treatment) and 10 months (follow up) following start of sessions.
| Milestone | Family-based Treatment for ARFID(FBT-ARFID) | Manualized Non-Specific Usual Care for ARFID(NSC) |
|---|---|---|
| Started | 141 | 144 |
| Children who started the study | 49 | 49 |
| Parents/caregivers who started the study | 92 | 95 |
| Children who completed the study | 48 | 48 |
| Parents/caregivers who completed the study | 90 | 93 |
| Completed | 138 | 141 |
| Not completed | 3 | 3 |
Expected Body Weights (EBW) percentages used will be calculated using Center for Disease Control Growth Chart metrics in children and adolescents with weight adjusted for age, gender, and height.
| Percentage of Expected Body Weight | FBT-ARFID - Children | Manualized Non- Specific Usual Care - Children |
|---|---|---|
| Expected Body Weight (EBW) | 90.21 (88.53 to 91.9) | 86.81 (85.12 to 88.5) |
A modification of the Parents versus Anorexia Nervosa Scale, a measure of parental self-efficacy at changing eating behaviors. The modifications to the scale are minor and consisted of changing the name of the disorder named in the scale's questions from AN to ARFID. This is a 7 item 5 point scale (for an overall score range of 7 to 35), where higher scores mean greater parental self-efficacy.
| score on a scale | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s) |
|---|---|---|
| Parents Versus Avoidant/Restrictive Food Intake Disorder (ARFID) | 21.63 ± 3.30 | 19.34 ± 2.77 |
Meals are recorded by video and then coded for behaviors associated with successful re-feeding using a procedure developed for Family Based Treatment. Criticisms were counts of critical comments to the child. Warmth was counts of positive comments to the child. Physical behaviors were counts of non-verbal praise and support to eat such as rubbing the child's back or loading the child's fork. Directives were counts of direct statements to the child to eat, try a food, or take a bite. Indirectives were statements to the child suggesting that they eat, try a food, or take a bite.
| behaviors | FBT-ARFID - Parent(s) / Caregiver(s) |
|---|---|
| Parental Criticism - baseline | 0.55 ± 0.89 |
| Parental Criticism - week 6 | 2.23 ± 4.76 |
| Parental Warmth - baseline | 1.90 ± 2.27 |
| Parental Warmth - week 6 | 4.3 ± 3.83 |
| Parental Physical Encouragement - baseline | 1.33 ± 2.54 |
| Parental Physical Encouragement - week 6 | 3.80 ± 5.50 |
| Parental Indirectives - baseline | 4.88 ± 3.88 |
| Parental Indirectives - week 6 | 8.28 ± 8.40 |
| Parental Directives - baseline | 4.70 ± 6.67 |
| Parental Directives - week 6 | 9.88 ± 14.95 |
The Pica, ARFID, Rumination Disorder Interview (PARDI) is a semi-structured interview designed to diagnose and evaluate symptom severity of Avoidant/Restrictive Food Intake Disorder (ARFID). Parents reported on their child's behavior using the PARDI. The severity score is comprised of 17 items on a 7 point scale (for an overall score range of 0 to 6), where greater scores indicate greater ARFID symptom severity.
| score on a scale | FBT-ARFID - Children | Manualized Non-Specific Usual Care for ARFID - Children |
|---|---|---|
| Baseline | 3.02 (2.79 to 3.26) | 3.15 (2.92 to 3.39) |
| 1 month | 2.67 (2.41 to 2.93) | 2.71 (2.49 to 2.93) |
| 2 months | 2.44 (2.12 to 2.75) | 2.67 (2.40 to 2.95) |
| 4 months | 2.37 (2.13 to 2.61) | 2.67 (2.43 to 2.92) |
| 10 months | 2.39 (2.13 to 2.65) | 2.66 (2.39 to 2.92) |
The Therapy Suitability and Patient Expectancy Scale is a measure with two subscales (Suitability and Success) and 2 items on 11 point scale (for an overall score of 0 to 10 on each subscale) that measures perceptions of the suitability and expectancy of the treatment provided and will be rated by parents. Higher scores on the subscales indicates greater perceptions of suitability and success. There is no TSPE total score.
| score on a scale | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s) |
|---|---|---|
| Suitable - session 1 | 6.78 ± 1.74 | 6.87 ± 1.82 |
| Suitable - session 3 | 6.89 ± 2.20 | 6.76 ± 1.82 |
| Suitable - session 5 | 6.96 ± 1.62 | 6.88 ± 1.78 |
| Suitable - session 7 | 6.61 ± 2.07 | 6.18 ± 2.14 |
| Suitable - session 9 | 6.58 ± 2.28 | 5.92 ± 2.20 |
| Suitable - session 11 | 6.39 ± 2.49 | 6.03 ± 2.29 |
| Suitable - session 13 | 6.42 ± 2.44 | 6.82 ± 2.39 |
| Successful - session 1 | 6.47 ± 1.75 | 6.67 ± 1.54 |
| Successful - session 3 | 6.60 ± 1.93 | 6.51 ± 1.65 |
| Successful - session 5 | 6.67 ± 1.68 | 6.40 ± 2.03 |
| Successful - session 7 | 6.17 ± 1.94 | 5.86 ± 2.26 |
| Successful - session 9 | 6.20 ± 2.52 | 5.33 ± 2.09 |
| Successful - session 11 | 5.84 ± 2.51 | 4.95 ± 2.18 |
| Successful - session 13 | 6.13 ± 2.46 | 5.59 ± 2.40 |
The Parenting Style Questionnaire is a 30 item 6 point validated measure of parenting style related to authoritative, authoritarian, and permissive style. This questionnaire is divided up into three subscales: authoritative (13 questions), authoritarian (13 questions), and permissive (4 questions). Each question was rated on a scale of 1 to 6. Item scores in each subscale were summed and averaged to create the subscale score (range: 1 to 6). For all question and subscale scores, greater scores suggest the more preferred parenting style. This questionnaire will be completed by parents/caregivers.
| score on a scale | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s) |
|---|---|---|
| Baseline - Authoritative | 5.14 ± 0.43 | 5.14 ± 0.37 |
| 4 months - Authoritative | 5.13 ± 0.45 | 5.16 ± 0.46 |
| Baseline - Authoritarian | 2.16 ± 0.54 | 2.18 ± 0.50 |
| 4 months - Authoritarian | 2.18 ± 0.51 | 2.12 ± 0.54 |
| Baseline - Permissive | 2.55 ± 0.63 | 2.62 ± 0.74 |
| 4 months - Permissive | 2.64 ± 0.63 | 2.70 ± 0.78 |
The Center for Epidemiological Studies Depression Scale for Children is a 20-item 4 point self-report scale (for an overall score range of 0 to 60) that measures child depression, with higher scores suggesting greater depressive symptoms.
| score on a scale | FBT-ARFID - Children | Manualized Non-Specific Usual Care for ARFID - Children |
|---|---|---|
| Baseline | 15.61 ± 10.26 | 15.66 ± 9.56 |
| 1 month | 13.43 ± 8.61 | 13.45 ± 7.91 |
| 2 months | 10.45 ± 7.52 | 15.09 ± 8.23 |
| 4 months | 10.30 ± 10.17 | 13.65 ± 11.21 |
| 10 months | 11.09 ± 7.97 | 15.37 ± 10.92 |
The Revised Children's Manifest Anxiety Scale Short is a 10 item 2 point scale (for an overall score range of 0 to 10) and is a validated measure of childhood anxiety and will be completed by children, with higher scores suggesting greater anxiety symptoms.
| score on a scale | FBT-ARFID - Children | Manualized Non-Specific Usual Care for ARFID - Children |
|---|---|---|
| Baseline | 2.70 ± 2.42 | 2.84 ± 2.49 |
| 1 month | 2.37 ± 2.46 | 2.55 ± 2.50 |
| 2 months | 1.84 ± 2.18 | 2.36 ± 2.19 |
| 4 months | 1.81 ± 2.40 | 2.49 ± 2.76 |
| 10 months | 1.72 ± 2.28 | 2.31 ± 2.28 |
The HAQ is an 11-item survey, each item scored on a 6 point scale (scores of -3, -2, -1, 1, 2, 3). This questionnaire measures the quality of the therapist-patient relationship. The form is divided up into two subscales: Helpfulness (5 questions for an score range of -15 to 15) and Cooperation (6 questions for a score range of -18 to 18). For each subscale, higher scores correspond to a more positive relationship and perception of the therapist's helpfulness and cooperation. The HAQ will be completed by parents/caregivers.
| score on a scale | FBT-ARFID - Parent(s)/ Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s)/ Caregiver(s) |
|---|---|---|
| Helpfulness - session 1 | 1.63 ± 4.16 | 2.12 ± 4.16 |
| Helpfulness - session 3 | 4.19 ± 4.55 | 1.72 ± 4.35 |
| Helpfulness - 1 month | 3.98 ± 5.64 | 2.07 ± 4.50 |
| Helpfulness - session 5 | 5.61 ± 4.19 | 2.74 ± 4.60 |
| Helpfulness - session 7 | 5.52 ± 4.40 | 2.73 ± 4.64 |
| Helpfulness - 2 months | 5.78 ± 5.14 | 1.77 ± 5.57 |
| Helpfulness - session 9 | 5.39 ± 5.22 | 1.49 ± 5.69 |
| Helpfulness - session 11 | 5.83 ± 5.49 | 3.41 ± 4.96 |
| Helpfulness - session 13 | 6.28 ± 5.84 | 5.77 ± 4.93 |
| Helpfulness - 4 months | 5.45 ± 7.06 | 3.90 ± 6.07 |
| Helpfulness - 10 months | 5.60 ± 7.31 | 3.98 ± 5.77 |
| Cooperation - session 1 | 9.72 ± 3.27 | 9.71 ± 3.13 |
| Cooperation - session 3 | 10.81 ± 4.89 | 10.09 ± 3.75 |
| Cooperation - 1 month | 10.46 ± 5.57 | 9.67 ± 3.36 |
| Cooperation - session 5 | 11.68 ± 4.47 | 10.92 ± 3.46 |
| Cooperation - session 7 | 11.46 ± 3.92 | 10.17 ± 3.56 |
| Cooperation - 2 months | 11.97 ± 4.39 | 8.47 ± 4.81 |
| Cooperation - session 9 | 12.03 ± 4.92 | 8.62 ± 4.28 |
| Cooperation - session 11 | 12.30 ± 5.04 | 10.32 ± 5.09 |
| Cooperation - session 13 | 12.58 ± 4.72 | 11.93 ± 4.97 |
| Cooperation - 4 months | 10.68 ± 6.88 | 10.68 ± 5.94 |
| Cooperation - 10 months | 10.47 ± 6.44 | 10.00 ± 5.18 |
The Schedule for Affective Disorders and Schizophrenia for School-Aged Children (K-SADS) is a widely used semi-structured interview detecting psychiatric disorders in children and adolescents. The individual items are scored on a 0 to 3 point rating scale, with scores of a 3 representing threshold criteria that leads to an additional diagnostic supplement based on the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) criteria evidence of the disorder. The K-SADS was administered to ascertain co-morbid psychiatric diagnoses prior to starting treatment.
| Participants | FBT-ARFID - Children | Manualized Non-Specific Usual Care for ARFID - Children |
|---|---|---|
| Attention Deficit Hyperactivity Disorder | 13 | 11 |
| Social Anxiety | 3 | 4 |
| Separation Anxiety | 1 | 0 |
| Generalized Anxiety | 5 | 4 |
| Major Depressive Disorder | 1 | 0 |
| Autism Spectrum Disorder | 2 | 3 |
| Obsessive-Compulsive Disorder | 1 | 1 |
| Disruptive Mood Disorder | 0 | 1 |
| Tic | 3 | 5 |
| Oppositional Defiant Disorder | 6 | 6 |
| Phobia | 3 | 4 |
| Tourette | 1 | 2 |
The Strengths and Difficulties Questionnaire assesses conduct, social, and peer behaviors consists of 25 items (questions) each rated on a scale from 0 to 2. The SDQ has with 5 subscales (emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship, and prosocial behavior). Each subscale consists of 5 questions resulting in a subscale score range of 0-10 (higher scores scores correspond to greater difficulties, except for prosocial behavior, where higher scores correspond to fewer difficulties). The total difficulties score is generated by summing scores from all the subscales except prosocial behavior, to create an overall score range of 0-40, where higher scores mean greater difficulties.
| score on a scale | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s) |
|---|---|---|
| Emotional Symptoms - baseline | 3.67 ± 2.17 | 3.56 ± 2.11 |
| Emotional Symptoms - 1 month | 3.93 ± 2.08 | 3.22 ± 2.32 |
| Emotional Symptoms - 2 months | 3.59 ± 2.28 | 3.65 ± 2.41 |
| Emotional Symptoms - 4 months | 3.30 ± 2.36 | 3.66 ± 2.33 |
| Emotional Symptoms - 10 months | 3.21 ± 2.27 | 3.33 ± 2.17 |
| Conduct Problems - baseline | 1.79 ± 1.53 | 1.75 ± 1.72 |
| Conduct Problems - 1 month | 1.92 ± 1.56 | 1.80 ± 1.51 |
| Conduct Problems - 2 months | 2.03 ± 1.68 | 1.76 ± 1.55 |
| Conduct Problems - 4 months | 1.76 ± 1.54 | 1.85 ± 1.84 |
| Conduct Problems - 10 months | 1.88 ± 1.70 | 1.73 ± 1.80 |
| Hyperactivity/Inattention - baseline | 4.91 ± 2.83 | 4.61 ± 3.15 |
| Hyperactivity/Inattention - 1 month | 5.12 ± 2.78 | 4.00 ± 3.05 |
| Hyperactivity/Inattention - 2 months | 4.92 ± 3.15 | 4.64 ± 3.06 |
| Hyperactivity/Inattention - 4 months | 5.02 ± 2.75 | 4.63 ± 3.09 |
| Hyperactivity/Inattention - 10 months | 4.78 ± 2.66 | 4.66 ± 3.30 |
| Peer Relationship Problems - baseline | 2.09 ± 1.68 | 2.21 ± 1.95 |
| Peer Relationship Problems - 1 month | 2.13 ± 1.73 | 2.26 ± 2.14 |
| Peer Relationship Problems - 2 months | 1.84 ± 1.70 | 2.32 ± 2.18 |
| Peer Relationship Problems - 4 months | 1.78 ± 1.63 | 2.41 ± 1.99 |
| Peer Relationship Problems - 10 months | 1.88 ± 1.65 | 2.35 ± 1.99 |
| Prosocial Behavior - baseline | 7.29 ± 1.61 | 6.92 ± 2.34 |
| Prosocial Behavior - 1 month | 7.45 ± 1.79 | 6.80 ± 2.55 |
| Prosocial Behavior - 2 months | 7.41 ± 1.90 | 7.43 ± 2.20 |
| Prosocial Behavior - 4 months | 7.72 ± 1.88 | 7.44 ± 2.59 |
| Prosocial Behavior - 10 months | 7.80 ± 1.78 | 7.41 ± 2.47 |
| Total Score - baseline | 12.49 ± 5.54 | 12.14 ± 6.50 |
| Total Score - 1 month | 13.10 ± 5.77 | 11.29 ± 6.12 |
| Total Score - 2 months | 12.40 ± 6.51 | 12.37 ± 5.87 |
| Total Score - 4 months | 11.87 ± 5.99 | 12.54 ± 6.43 |
| Total Score - 10 months | 11.76 ± 6.12 | 12.04 ± 6.64 |
The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression on a 4-point scale (overall scores ranging from 0 to 63). This measure also includes questions about suicidal ideation and intent. Higher scores suggest greater depressive symptoms.
| score on a scale | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s) |
|---|---|---|
| Baseline | 7.10 ± 6.74 | 5.62 ± 3.57 |
| 4 months | 7.39 ± 8.45 | 5.51 ± 4.19 |
The Beck Anxiety Inventory consists of 21 self-reported items assessing a participant's anxiety symptoms on a 4-point (0 to 3) scale (for an overall score range of 0 to 63), where higher scores suggests greater anxiety symptoms.
| score on a scale | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s) |
|---|---|---|
| Baseline | 6.06 ± 7.27 | 4.22 ± 3.79 |
| 4 months | 6.13 ± 7.13 | 3.93 ± 3.81 |
The 36-Item Short Form is a 36 item scale and is a general measure of physical and mental health functioning. This form is divided up into 8 subscales: vitality (4 questions), physical functioning (10 questions), bodily pain (2 questions), general health perceptions (5 questions), physical role functioning (4 questions), emotional role functioning (3 questions), social role functioning (2 questions), and mental health (5 questions). 1 question is not included in subscale scoring. The questions range between 2 and 6 points (1 to 2, 1 to 3, 1 to 5, and 1 to 6) and then are each re-coded (scale of 0 to 100), summed, and averaged to create the subscale score (score range of 0 to 100). For all subscales scores, greater scores suggest less disability. This assessment will be taken by the parents/caregivers.
| score on a scale | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s) |
|---|---|---|
| Vitality | 52.04 ± 16.68 | 56.31 ± 13.71 |
| Physical Functioning | 90.10 ± 14.93 | 91.63 ± 14.98 |
| Bodily Pain | 82.40 ± 16.14 | 84.67 ± 13.93 |
| General Health Perceptions | 67.95 ± 16.24 | 73.37 ± 11.52 |
| Physical Role Functioning | 89.03 ± 21.44 | 93.62 ± 11.73 |
| Emotional Role Functioning | 80.27 ± 27.78 | 88.78 ± 17.23 |
| Social Role Functioning | 83.55 ± 23.24 | 90.18 ± 11.41 |
| Mental Health | 72.71 ± 15.74 | 76.29 ± 11.35 |
Bandura's General Self-Efficacy Scale is a 10-item 4 point self-report scale (for an overall score range of 10 to 40) of general self-efficacy, where higher scores mean higher self-efficacy. This measure was completed by parents for their general self-efficacy score.
| score on a scale | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s) |
|---|---|---|
| Baseline | 31 ± 2.95 | 32.07 ± 2.42 |
| Session 1 | 31.10 ± 3.18 | 31.53 ± 3.06 |
| Session 2 | 30.55 ± 3.74 | 31.53 ± 2.97 |
| Session 3 | 31.02 ± 4.31 | 31.02 ± 3.13 |
| Session 4 | 30.76 ± 4.18 | 31.36 ± 3.30 |
| 1 month | 30.63 ± 4.62 | 31.40 ± 3.00 |
| Session 5 | 30.85 ± 4.70 | 31.40 ± 3.12 |
| Session 6 | 31.03 ± 4.41 | 31.52 ± 3.17 |
| Session 7 | 31.15 ± 4.65 | 31.52 ± 3.08 |
| Session 8 | 30.98 ± 4.63 | 31.44 ± 3.16 |
| 2 months | 31.67 ± 4.88 | 31.04 ± 3.03 |
| Session 9 | 30.97 ± 4.75 | 30.88 ± 4.19 |
| Session 10 | 31.27 ± 4.94 | 31.48 ± 3.24 |
| Session 11 | 31.37 ± 4.85 | 30.93 ± 2.41 |
| Session 12 | 30.77 ± 4.92 | 31.60 ± 3.13 |
| Session 13 | 30.84 ± 4.84 | 31.31 ± 2.93 |
| Session 14 | 30.40 ± 4.80 | 31.31 ± 3.31 |
| 4 months | 31.84 ± 4.81 | 32.27 ± 3.63 |
| 10 months | 31.89 ± 4.77 | 32.47 ± 3.17 |
The Parenting Sense of Competence Scale contains 17 items measuring a participant's sense of competence in their parenting skills and as a parent of a child on a 6 scale (for an overall score range of 17 to 102), with higher scores meaning greater parental efficacy.
| score on a scale | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non-Specific Usual Care for ARFID - Parent(s) / Caregiver(s) |
|---|---|---|
| Baseline | 70.92 ± 8.79 | 70.28 ± 8.59 |
| Session 1 | 69.15 ± 10.17 | 70.37 ± 10.31 |
| Session 2 | 70.97 ± 9.55 | 70.81 ± 10.18 |
| Session 3 | 71.18 ± 9.43 | 71.61 ± 9.80 |
| Session 4 | 71.04 ± 9.51 | 70.80 ± 11.34 |
| 1 month | 71.79 ± 9.91 | 70.22 ± 10.66 |
| Session 5 | 71.22 ± 8.34 | 72.07 ± 12.53 |
| Session 6 | 71.74 ± 9.20 | 71.30 ± 12.26 |
| Session 7 | 72.74 ± 9.01 | 73.66 ± 11.11 |
| Session 8 | 71.82 ± 10.28 | 72.73 ± 9.81 |
| 2 month | 73.02 ± 10.08 | 71.96 ± 9.14 |
| Session 9 | 70.91 ± 10.41 | 72.60 ± 11.88 |
| Session 10 | 72.04 ± 8.72 | 74.43 ± 10.83 |
| Session 11 | 72.08 ± 10.50 | 72.35 ± 10.22 |
| Session 12 | 71.53 ± 9.63 | 72.61 ± 10.67 |
| Session 13 | 72.74 ± 10.55 | 74.21 ± 10.51 |
| Session 14 | 72.31 ± 10.35 | 73.71 ± 9.25 |
| 4 months | 73.29 ± 11.54 | 74.16 ± 11.25 |
| 10 months | 73.71 ± 12.04 | 74.34 ± 8.82 |
Collected over Pre-treatment (1 week) plus 10 months of weekly sessions and follow-up. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| FBT-ARFID - Children | 0/49 (0%) | 1/49 (2%) | 0/49 (0%) |
| Manualized Non- Specific Usual Care - Children | 0/49 (0%) | 0/49 (0%) | 0/49 (0%) |
| FBT-ARFID - Parent(s) / Caregiver(s) | 0/92 (0%) | 0/92 (0%) | 0/92 (0%) |
| Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s) | 0/95 (0%) | 0/95 (0%) | 0/95 (0%) |
| Event | FBT-ARFID - Children | Manualized Non- Specific Usual Care - Children | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s) |
|---|---|---|---|---|
| PneumoniaRespiratory, thoracic and mediastinal disorders | 1/49 | 0/49 | 0/92 | 0/95 |
| AsthmaRespiratory, thoracic and mediastinal disorders | 1/49 | 0/49 | 0/92 | 0/95 |
| Age, Continuous(years) | FBT-ARFID - Children | Manualized Non- Specific Usual Care - Children | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s) | Total |
|---|---|---|---|---|---|
| Children | 9.6 ± 2.0 | 9.8 ± 1.9 | — | — | 9.7 ± 2.0 |
| Parent(s) / Caregiver(s) | — | — | 43.12 ± 6.49 | 44.4 ± 6.38 | 43.78 ± 6.49 |
| Sex: Female, Male(Participants) | FBT-ARFID - Children | Manualized Non- Specific Usual Care - Children | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s) | Total |
|---|---|---|---|---|---|
| Female | 17 | 23 | 49 | 47 | 136 |
| Male | 32 | 26 | 43 | 43 | 144 |
| Ethnicity (NIH/OMB)(Participants) | FBT-ARFID - Children | Manualized Non- Specific Usual Care - Children | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s) | Total |
|---|---|---|---|---|---|
| Hispanic or Latino | 13 | 7 | 15 | 7 | 42 |
| Not Hispanic or Latino | 36 | 42 | 77 | 85 | 240 |
| Unknown or Not Reported | 0 | 0 | 0 | 3 | 3 |
| Race (NIH/OMB)(Participants) | FBT-ARFID - Children | Manualized Non- Specific Usual Care - Children | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s) | Total |
|---|---|---|---|---|---|
| American Indian or Alaska Native | 3 | 1 | 4 | 0 | 8 |
| Asian | 5 | 3 | 9 | 14 | 31 |
| Native Hawaiian or Other Pacific Islander | 0 | 1 | 0 | 1 | 2 |
| Black or African American | 1 | 1 | 2 | 0 | 4 |
| White | 31 | 33 | 70 | 71 | 205 |
| More than one race | 9 | 10 | 7 | 7 | 33 |
| Unknown or Not Reported | 0 | 0 | 0 | 2 | 2 |
| Region of Enrollment(Participants) | FBT-ARFID - Children | Manualized Non- Specific Usual Care - Children | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s) | Total |
|---|---|---|---|---|---|
| United States | 49 | 49 | 92 | 95 | 285 |
| Percentage of Expected Body Weight(Percentage of Expected Body Weight) | FBT-ARFID - Children | Manualized Non- Specific Usual Care - Children | FBT-ARFID - Parent(s) / Caregiver(s) | Manualized Non- Specific Usual Care - Parent(s) / Caregiver(s) | Total |
|---|---|---|---|---|---|
| Mean | 84.5 ± 4.2 | 84.8 ± 5.0 | — | — | 84.6 ± 4.6 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Dec 2020 to primary completion in Jul 2025, 55 months.
Results were first posted in Oct 2026, 1 year 3 months after primary completion.
Of 16 interventional studies with no phase under Avoidant Restrictive Food Intake Disorder, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 43. This study's 55 months is above that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Avoidant Restrictive Food Intake Disorder →